Park Avenue Securities’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.93M Buy
+85,970
New +$5.93M 0.05% 246
2025
Q1
Sell
-102,657
Closed -$8.83M 1420
2024
Q4
$8.83M Buy
102,657
+7,103
+7% +$611K 0.09% 153
2024
Q3
$11.4M Sell
95,554
-15,217
-14% -$1.81M 0.13% 113
2024
Q2
$15.8M Buy
110,771
+7,832
+8% +$1.12M 0.19% 77
2024
Q1
$13.2M Buy
102,939
+14,775
+17% +$1.9M 0.17% 87
2023
Q4
$9.12M Buy
88,164
+3,359
+4% +$348K 0.13% 107
2023
Q3
$7.71M Buy
84,805
+4,769
+6% +$434K 0.12% 113
2023
Q2
$6.48M Buy
80,036
+3,966
+5% +$321K 0.1% 129
2023
Q1
$6.05M Sell
76,070
-48
-0.1% -$3.82K 0.1% 128
2022
Q4
$5.15M Buy
76,118
+804
+1% +$54.4K 0.09% 142
2022
Q3
$3.75M Buy
75,314
+4,142
+6% +$206K 0.07% 165
2022
Q2
$3.97M Buy
71,172
+20,824
+41% +$1.16M 0.08% 162
2022
Q1
$2.8M Buy
50,348
+19,188
+62% +$1.07M 0.05% 217
2021
Q4
$1.75M Buy
31,160
+556
+2% +$31.1K 0.03% 303
2021
Q3
$1.47M Buy
30,604
+3,612
+13% +$173K 0.03% 298
2021
Q2
$1.13M Buy
26,992
+4,854
+22% +$203K 0.02% 345
2021
Q1
$746K Buy
22,138
+3,976
+22% +$134K 0.02% 461
2020
Q4
$634K Buy
18,162
+2,390
+15% +$83.4K 0.02% 443
2020
Q3
$548K Buy
15,772
+2,134
+16% +$74.1K 0.02% 412
2020
Q2
$447K Buy
+13,638
New +$447K 0.02% 407
2020
Q1
Sell
-8,992
Closed -$260K 504
2019
Q4
$260K Sell
8,992
-2,944
-25% -$85.1K 0.01% 503
2019
Q3
$309K Buy
+11,936
New +$309K 0.01% 402
2019
Q2
Sell
-10,266
Closed -$268K 405
2019
Q1
$268K Buy
+10,266
New +$268K 0.01% 337